Related Experiment Video
Updated: Aug 14, 2026

Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury
Published on: September 18, 2011
Spinal muscular atrophy: recent advances and future prospects
Sophie Nicole1, Carmen Cifuentes Diaz, Tony Frugier
1Molecular Neurogenetics Laboratory, Institut National de la Santé et de la Recherche Médicale (INSERM), Université d'Evry, E.9913, Genopole, 2 rue Gaston Crémieux, CP 5724, 91057 Evry, France.
Spinal muscular atrophies (SMA) are severe genetic disorders causing motor neuron degeneration and muscle atrophy. Research into the SMN1 gene and SMA mouse models advances understanding and therapeutic development for this childhood disease.
Area of Science:
- Genetics
- Neuroscience
- Pediatrics
Background:
- Spinal muscular atrophies (SMA) involve lower motor neuron degeneration, leading to muscle paralysis and atrophy.
- Childhood SMA is a common autosomal recessive disorder and a leading genetic cause of mortality in children.
- Mutations in the SMN1 gene are the primary cause of SMA.
Purpose of the Study:
- To review the genetic basis of SMA.
- To enhance understanding of SMN protein function.
- To discuss the significance of SMA mouse models in research.
Main Methods:
- Genetic analysis of the SMN1 gene.
- Review of scientific literature on SMN protein.
- Examination of data from established SMA mouse models.
Main Results:
- Identified SMN1 gene mutations as the cause of SMA.
- Highlighted the role of SMN protein in motor neuron survival.
- Demonstrated the utility of SMA mouse models for disease study.
Conclusions:
- Advances in understanding SMA's genetic basis and pathophysiology are crucial.
- SMN protein function is key to motor neuron health.
- SMA mouse models are vital tools for developing future therapeutic strategies for this neurodegenerative disease.
More Related Videos
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Parkinson's Disease: Overview
Myasthenia Gravis ll: Pathophysiology
Alterations in Muscle Tone lll

